Search
for
Sort by
Research 481–510 of 1000+
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience
- JAK Inhibitors in Down Syndrome: Alopecia Areata Resolution and Vitiligo Improvement with Baricitinib
- Jak inhibitors in the treatment of alopecia areata - a literature review
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- Public Interest in JAK Inhibitors for Alopecia Areata: A Google Trend Analysis (Preprint)
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Experience in treating multifocal alopecia areata in a child with Jak kinase inhibitors
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- Alopecia Areata: JAK Inhibitors—PRP and Exosomes
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- JAK-inhibitors in dermatology: current evidence and future applications
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature